Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …

Background Physical sequelae related to multi-drug resistant tuberculosis (MDR-TB) and
extensively drug-resistant tuberculosis (XDR-TB) are emerging and under-recognised …

Bedaquiline, a diarylquinoline, improved cure rates when added to a multidrug-resistant
tuberculosis (MDR-TB) treatment regimen in a previous placebo-controlled, phase 2 trial …

ABSTRACT Multidrug‐resistant (MDR) tuberculosis (TB) denotes bacillary resistance to at
least isoniazid and rifampicin. Extensively drug‐resistant (XDR) TB is MDR‐TB with …

Introduction: Antiretroviral and anti-tuberculosis (TB) drugs are often co-administered in
people living with HIV (PLWH). Early initiation of antiretroviral therapy (ART) during TB …

Background Gender differences among patients with drug resistant tuberculosis (DRTB) and
HIV co-infection could affect treatment outcomes. We compared characteristics and …

Background After a history of poor treatments for rifampin-resistant tuberculosis (RR-TB),
recent advances have resulted in shorter, more effective treatments. However, they are not …

The role of pyrazinamide in the current treatment of multidrug-resistant (MDR) tuberculosis
(TB) is uncertain. From a territory-wide registry of MDR-TB cases diagnosed between 1995 …

Drug-resistant forms of tuberculosis (DR-TB) are a significant cause of global morbidity and
mortality and the treatment of DR-TB is characterized by long and toxic regimens that result …

Oxidative stress is a common feature of tuberculosis (TB), and persons with reduced
antioxidants are at more risk of TB. TB patients with relatively severe oxidative stress had …